Pharma Sues Trump Over Medicare Drug Price Rule

PhRMA has filed a lawsuit against the Trump administration challenging a Medicare rule that benchmarks drug prices to overseas rates. The group argues the policy exceeds federal authority.

Xurve View
Insights:
U.S. dollar banknotes and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration

The pharmaceutical industry's main lobby group filed a lawsuit on Wednesday to block the United States administration's GLOBE rule, which benchmarks domestic drug prices to lower overseas costs in Medicare. The legal challenge targets a policy designed to reshape hospital drug pricing for millions of elderly and disabled beneficiaries. The filing opens a new battle over federal price controls after the administration secured voluntary cuts from more than two dozen drugmakers.